BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19865714)

  • 1. Synthetic dinucleotide mRNA cap analogs with tetraphosphate 5',5' bridge containing methylenebis(phosphonate) modification.
    Rydzik AM; Lukaszewicz M; Zuberek J; Kowalska J; Darzynkiewicz ZM; Darzynkiewicz E; Jemielity J
    Org Biomol Chem; 2009 Nov; 7(22):4763-76. PubMed ID: 19865714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biochemical studies of tetraphosphate 5' mRNA cap analogs bearing bisphosphonate modification.
    Rydzik A; Zuberek J; Kowalska J; Lukaszewicz M; Darzynkiewicz E; Jemielity J
    Nucleic Acids Symp Ser (Oxf); 2008; (52):287-8. PubMed ID: 18776366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorothioate analogs of m7GTP are enzymatically stable inhibitors of cap-dependent translation.
    Kowalska J; Lukaszewicz M; Zuberek J; Ziemniak M; Darzynkiewicz E; Jemielity J
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1921-5. PubMed ID: 19269171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of anti-reverse cap analogs (ARCAs) and their applications in mRNA translation and stability.
    Grudzien-Nogalska E; Stepinski J; Jemielity J; Zuberek J; Stolarski R; Rhoads RE; Darzynkiewicz E
    Methods Enzymol; 2007; 431():203-27. PubMed ID: 17923237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mRNA cap analogues substituted in the tetraphosphate chain with CX2: identification of O-to-CCl2 as the first bridging modification that confers resistance to decapping without impairing translation.
    Rydzik AM; Warminski M; Sikorski PJ; Baranowski MR; Walczak S; Kowalska J; Zuberek J; Lukaszewicz M; Nowak E; W Claridge TD; Darzynkiewicz E; Nowotny M; Jemielity J
    Nucleic Acids Res; 2017 Sep; 45(15):8661-8675. PubMed ID: 28666355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and properties of mRNA cap analogs containing imidodiphosphate moiety--fairly mimicking natural cap structure, yet resistant to enzymatic hydrolysis.
    Rydzik AM; Kulis M; Lukaszewicz M; Kowalska J; Zuberek J; Darzynkiewicz ZM; Darzynkiewicz E; Jemielity J
    Bioorg Med Chem; 2012 Mar; 20(5):1699-710. PubMed ID: 22316555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The first examples of mRNA cap analogs bearing boranophosphate modification.
    Kowalska J; Zuberek J; Darzynkiewicz ZM; Lukaszewicz M; Darzynkiewicz E; Jemielity J
    Nucleic Acids Symp Ser (Oxf); 2008; (52):289-90. PubMed ID: 18776367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatically stable 5' mRNA cap analogs: synthesis and binding studies with human DcpS decapping enzyme.
    Kalek M; Jemielity J; Darzynkiewicz ZM; Bojarska E; Stepinski J; Stolarski R; Davis RE; Darzynkiewicz E
    Bioorg Med Chem; 2006 May; 14(9):3223-30. PubMed ID: 16431118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m7GTP alphaS is a strong and stable inhibitor of cap-dependent translation.
    Kowalska J; Lukaszewicz M; Zuberek J; Ziemniak M; Strenkowska M; Darzynkiewicz E; Jemielity J
    Nucleic Acids Symp Ser (Oxf); 2008; (52):291-2. PubMed ID: 18776368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of mRNA cap analogs containing phosphorothioate substitutions that bind tightly to eIF4E and are resistant to the decapping pyrophosphatase DcpS.
    Kowalska J; Lewdorowicz M; Zuberek J; Grudzien-Nogalska E; Bojarska E; Stepinski J; Rhoads RE; Darzynkiewicz E; Davis RE; Jemielity J
    RNA; 2008 Jun; 14(6):1119-31. PubMed ID: 18430890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.
    Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y
    RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermodynamics of mRNA 5' cap binding by eukaryotic translation initiation factor eIF4E.
    Niedzwiecka A; Darzynkiewicz E; Stolarski R
    Biochemistry; 2004 Oct; 43(42):13305-17. PubMed ID: 15491137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5' cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins.
    Niedzwiecka A; Marcotrigiano J; Stepinski J; Jankowska-Anyszka M; Wyslouch-Cieszynska A; Dadlez M; Gingras AC; Mak P; Darzynkiewicz E; Sonenberg N; Burley SK; Stolarski R
    J Mol Biol; 2002 Jun; 319(3):615-35. PubMed ID: 12054859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel cap analogs for in vitro synthesis of mRNAs with high translational efficiency.
    Grudzien E; Stepinski J; Jankowska-Anyszka M; Stolarski R; Darzynkiewicz E; Rhoads RE
    RNA; 2004 Sep; 10(9):1479-87. PubMed ID: 15317978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of potential inhibitors of eIF4E cap binding to 7-methyl GTP.
    Ghosh P; Park C; Peterson MS; Bitterman PB; Polunovsky VA; Wagner CR
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2177-80. PubMed ID: 15808492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biophysical approach to studies of cap-eIF4E interaction by synthetic cap analogs.
    Niedzwiecka A; Stepinski J; Antosiewicz JM; Darzynkiewicz E; Stolarski R
    Methods Enzymol; 2007; 430():209-45. PubMed ID: 17913640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of electric charge variation at residues 209 and 159 on the interaction of eIF4E with the mRNA 5' terminus.
    Zuberek J; Jemielity J; Jablonowska A; Stepinski J; Dadlez M; Stolarski R; Darzynkiewicz E
    Biochemistry; 2004 May; 43(18):5370-9. PubMed ID: 15122903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate mRNA cap analog attached to Sepharose for affinity chromatography of decapping enzymes.
    Szczepaniak SA; Jemielity J; Zuberek J; Kufel J; Darzynkiewicz E
    Nucleic Acids Symp Ser (Oxf); 2008; (52):295-6. PubMed ID: 18776370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biochemical properties of novel mRNA 5' cap analogs resistant to enzymatic hydrolysis.
    Kalek M; Jemielity J; Grudzien E; Zuberek J; Bojarska E; Cohen LS; Stepinski J; Stolarski R; Davis RE; Rhoads RE; Darzynkiewicz E
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):615-21. PubMed ID: 16247999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of eukaryotic mRNA stability via the cap-binding translation complex eIF4F.
    Ramirez CV; Vilela C; Berthelot K; McCarthy JE
    J Mol Biol; 2002 May; 318(4):951-62. PubMed ID: 12054793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.